H. Williams

发表

Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder

D. Rujescu, I. Giegling, G. Kirov, 2011, Molecular Psychiatry.

Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).

M J Owen, A Preece, G. Kirov, 2004, Archives of general psychiatry.

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia

M C O'Donovan, A Preece, N. Williams, 2003, Molecular Psychiatry.

Improved diagnosis of rare disease patients through application of constrained coding region annotation and de novo status.

H. Williams, C. Odhams, Genomics England Research Consortium, 2022, medRxiv.

No evidence that rare coding variants in ZNF804A confer risk of schizophrenia

N. Craddock, M. O’Donovan, P. Holmans, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Multicenter linkage study of schizophrenia loci on chromosome 22q

M. O’Donovan, W. Maier, J. Mallet, 2004, Molecular Psychiatry.

A systematic genomewide linkage study in 353 sib pairs with schizophrenia.

M. Owen, M. O’Donovan, L. Jones, 2003, American journal of human genetics.

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

M C O'Donovan, M J Owen, T G Schulze, 2009, Molecular Psychiatry.

Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis

G. Kirov, M. Owen, M. O’Donovan, 2003, British Journal of Psychiatry.

Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia

G. Kirov, N. Williams, N. Norton, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Background Velo-cardio-facial syndrome (VCFS) is associatedwith interstitial deletions of chromosome 22q11.About 30% of patientswithVCFS

G. Kirov, M. Owen, M. O’Donovan, 2003 .

Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach

G. Kirov, M. Owen, M. Hamshere, 2002, Molecular Psychiatry.

Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha

D. Rujescu, G. Kirov, D. Grozeva, 2010, Molecular Psychiatry.

Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia

E. Banks, M. O’Donovan, S. Mccarroll, 2015, Translational Psychiatry.

Characterisation, mutation detection, and association analysis of alternative promoters and 5′ UTRs of the human dopamine D3 receptor gene in schizophrenia

R. Anney, M. Hamshere, N. Norton, 2002, Molecular Psychiatry.

Genome wide significant linkage in schizophrenia conditioning on occurrence of depressive episodes

N. Craddock, M. Owen, M. O’Donovan, 2005, Journal of Medical Genetics.

Mutation screening of the KCNN3 gene reveals a rare frameshift mutation

L. Jones, N. Norton, A. Cardno, 2001, Molecular Psychiatry.

Association between PRODH and schizophrenia is not confirmed

G. Kirov, M. Owen, I. Nikolov, 2003, Molecular Psychiatry.

Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor

N. Williams, N. Norton, H. Williams, 2002, Molecular Psychiatry.

Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene

K. Davis, N. Craddock, J. Buxbaum, 2008, Molecular Psychiatry.

Mutation screening of the Homer gene family and association analysis in schizophrenia

N. Norton, G. Spurlock, S. Zammit, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia

V. Moskvina, N. Norton, M. O’Donovan, 2007, Schizophrenia Research.

Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder

D. Rujescu, I. Giegling, M. Owen, 2011, Genes, brain, and behavior.

Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans

Sam R. Miller, N. Craddock, M. Owen, 2011, Molecular Psychiatry.

Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia

M C O'Donovan, P M Visscher, P. Visscher, 2011, Molecular Psychiatry.

University of Groningen Fine mapping of ZNF 804 A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder

D. Rujescu, I. Giegling, M. Gill, 2017 .

A family based study of catechol‐O‐methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD)

M. Owen, A. Thapar, K. Langley, 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.